Valuation: Repligen Corporation

Market Cap 1TCr 888.39Cr 830.79Cr 757.08Cr 1.43TCr 96TCr 1.44TCr 10TCr 3.89TCr 49TCr 3.76TCr 3.67TCr 1,57500Cr P/E 2026 *
234x
P/E 2027 * 103x
Enterprise Value 973.72Cr 864.86Cr 808.79Cr 737.03Cr 1.39TCr 94TCr 1.41TCr 9.78TCr 3.79TCr 48TCr 3.66TCr 3.58TCr 1,53400Cr EV / Sales 2026 *
11.8x
EV / Sales 2027 * 9.8x
Free-Float
94.32%
Yield 2026 *
-
Yield 2027 * -
1 week-5.54%
Current month-6.73%
1 month+8.37%
3 months+30.11%
6 months+54.94%
Current year+13.25%
1 week 158.35
Extreme 158.35
173.65
1 month 139.45
Extreme 139.45
173.65
3 years 86.86
Extreme 86.86
194.4
5 years 86.86
Extreme 86.86
264
10 years 24.04
Extreme 24.04
281
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Director/Board Member 61 01/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
-6.73%+5.08%+27.75%+4.48% 1.08TCr
-2.17%-4.33%-27.56%-0.17% 17TCr
+0.17%-2.34%-8.83%+10.31% 11TCr
-0.88%+1.19%-25.04%-0.11% 11TCr
-0.69%-0.07%-47.78%-12.45% 7.6TCr
+3.17%-0.03%-0.64%+72.13% 5.73TCr
-1.29%+2.60%+13.18%+58.94% 5.02TCr
-0.52%-0.65%-6.74%-31.12% 4.88TCr
-0.85%+0.85%-16.51%+18.41% 4.11TCr
-0.07%-1.42%+30.49%-7.58% 3.26TCr
Average -0.34%-0.28%-6.17%+11.28% 7.7TCr
Weighted average by Cap. -0.63%-1.02%-15.70%+8.93%

Financials

2026 *2027 *
Net sales 83Cr 73Cr 69Cr 63Cr 117.85Cr 7.96TCr 119.47Cr 831.04Cr 321.7Cr 4.06TCr 310.51Cr 303.77Cr 13TCr 98Cr 87Cr 81Cr 74Cr 139.1Cr 9.4TCr 141.01Cr 980.85Cr 379.7Cr 4.79TCr 366.48Cr 358.54Cr 15TCr
Net income 4.19Cr 3.72Cr 3.48Cr 3.17Cr 5.97Cr 403.63Cr 6.06Cr 42Cr 16Cr 205.56Cr 16Cr 15Cr 660.25Cr 9.88Cr 8.78Cr 8.21Cr 7.48Cr 14Cr 951.64Cr 14Cr 99Cr 38Cr 484.66Cr 37Cr 36Cr 1.56TCr
Net Debt -26Cr -24Cr -22Cr -20Cr -38Cr -2.55TCr -38Cr -266.16Cr -103.03Cr -1.3TCr -99Cr -97Cr -4.17TCr -44Cr -39Cr -36Cr -33Cr -62Cr -4.22TCr -63Cr -440.15Cr -170.39Cr -2.15TCr -164.46Cr -160.89Cr -6.9TCr
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
-
Date Price Change
01/26/01 €158.60 -6.73%
30/26/30 €170.05 -0.90%
29/26/29 €171.60 +0.26%
28/26/28 €171.15 +2.76%
25/26/25 €166.55 -0.80%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
177.23USD
Average target price
189.70USD
Spread / Average Target
+7.04%

Quarterly revenue - Rate of surprise